Entry
Name
Colorectal cancer
Description
Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes (TSG). Two major mechanisms of genomic instability have been identified in sporadic CRC progression. The first, known as chromosomal instability (CIN), results from a series of genetic changes that involve the activation of oncogenes such as K-ras and inactivation of TSG such as p53, DCC/Smad4, and APC. The second, known as microsatellite instability (MSI), results from inactivation of the DNA mismatch repair genes MLH1 and/or MSH2 by hypermethylation of their promoter, and secondary mutation of genes with coding microsatellites, such as transforming growth factor receptor II (TGF-RII) and BAX. Hereditary syndromes have germline mutations in specific genes (mutation in the tumour suppressor gene APC on chromosome 5q in FAP, mutated DNA mismatch repair genes in HNPCC).
Class
Human Diseases; Cancer: specific types
BRITE hierarchy
Pathway map
Disease
Orthology
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153 ]
K02085 APC; adenomatosis polyposis coli protein
K02158 BAD; Bcl-2-antagonist of cell death
K02159 BAX; apoptosis regulator BAX
K02161 BCL2; apoptosis regulator Bcl-2
K02620 TCF7, TCF-1; transcription factor 7
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04357 EGF; epidermal growth factor
K04364 GRB2; growth factor receptor-bound protein 2
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1 ]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1 ]
K04368 MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2 ]
K04369 MAP2K2, MEK2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2 ]
K04377 MYC; Myc proto-oncogene protein
K04379 FOS; proto-oncogene protein c-fos
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24 ]
K04448 JUN; transcription factor AP-1
K04451 TP53, P53; tumor protein p53
K04490 TCF7L1; transcription factor 7-like 1
K04491 TCF7L2; transcription factor 7-like 2
K04492 LEF1; lymphoid enhancer-binding factor 1
K04500 SMAD2; mothers against decapentaplegic homolog 2
K04501 SMAD4; mothers against decapentaplegic homolog 4
K04503 CCND1; G1/S-specific cyclin-D1
K04513 RHOA; Ras homolog gene family, member A
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
K06765 DCC; deleted in colorectal carcinoma
K07203 MTOR, FRAP, TOR; serine/threonine-protein kinase mTOR [EC:2.7.11.1 ]
K07827 KRAS, KRAS2; GTPase KRas
K07834 RALA; Ras-related protein Ral-A
K07835 RALB; Ras-related protein Ral-B
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K08731 BIRC5; baculoviral IAP repeat-containing protein 5
K08732 RALGDS; ral guanine nucleotide dissociation stimulator
K08733 APPL1, DIP13A; DCC-interacting protein 13 alpha
K08734 MLH1; DNA mismatch repair protein MLH1
K08735 MSH2; DNA mismatch repair protein MSH2
K08736 MSH3; DNA mismatch repair protein MSH3
K08737 MSH6; DNA mismatch repair protein MSH6
K08774 TGFA; transforming growth factor, alpha
K08845 ARAF, ARAF1; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1 ]
K10131 PMAIP1, NOXA; phorbol-12-myristate-13-acetate-induced protein 1
K10132 BBC3, PUMA; Bcl-2-binding component 3
K10140 DDB2; DNA damage-binding protein 2
K13375 TGFB1; transforming growth factor beta-1
K13376 TGFB2; transforming growth factor beta-2
K13377 TGFB3; transforming growth factor beta-3
K14021 BAK, BAK1; Bcl-2 homologous antagonist/killer
K16341 BCL2L11, BIM; Bcl-2-like protein 11
K23605 SMAD3; mothers against decapentaplegic homolog 3
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Grady WM.
Title
Genomic instability and colon cancer.
Journal
Reference
Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
Title
Microsatellite instability in colorectal cancer.
Journal
Reference
Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
Title
Hereditary non-polyposis colorectal cancer: an updated review.
Journal
Reference
Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
Title
Colorectal cancer: genetics of development and metastasis.
Journal
Reference
Authors
Lynch HT, de la Chapelle A.
Title
Hereditary colorectal cancer.
Journal
Reference
Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
Title
The significance of unstable chromosomes in colorectal cancer.
Journal
Reference
Authors
Behrens J.
Title
Cadherins and catenins: role in signal transduction and tumor progression.
Journal
Reference
Authors
Behrens J.
Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
Journal
Reference
Authors
Behrens J, Lustig B.
Title
The Wnt connection to tumorigenesis.
Journal
Reference
Authors
Polakis P.
Title
The adenomatous polyposis coli (APC) tumor suppressor.
Journal
Reference
Authors
Janssen KP.
Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
Journal
Reference
Authors
Adjei AA.
Title
Blocking oncogenic Ras signaling for cancer therapy.
Journal
Reference
Authors
Arakawa H.
Title
Netrin-1 and its receptors in tumorigenesis.
Journal
Reference
Authors
Mehlen P, Fearon ER.
Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
Journal
Reference
Authors
Peltomaki P.
Title
DNA mismatch repair and cancer.
Journal
Reference
Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
Title
TGF-beta signaling in colon cancer cells.
Journal
Reference
Authors
Roman C, Saha D, Beauchamp R.
Title
TGF-beta and colorectal carcinogenesis.
Journal
Reference
Authors
Watson AJ.
Title
An overview of apoptosis and the prevention of colorectal cancer.
Journal
Reference
Authors
Watson AJ.
Title
Apoptosis and colorectal cancer.
Journal
Reference
Authors
Houlston RS.
Title
What we could do now: molecular pathology of colorectal cancer.
Journal
Reference
Authors
Hector S, Prehn JH
Title
Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review.
Journal
Reference
Authors
Karnoub AE, Weinberg RA
Title
Ras oncogenes: split personalities.
Journal
Reference
Authors
Wang D, Xia D, Dubois RN
Title
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer.
Journal
Reference
Authors
Dasari A, Messersmith WA
Title
New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.
Journal
Reference
Authors
Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW
Title
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.
Journal
Related pathway